Y90 Radioembolization for Locally Advanced HCC

UCLA Health

S. Padia

Combined Hepatocellular-Cholangiocarcinoma: Diagnosis and Management

Integrity CE

J. Birkness-Gartman

HCC Percutaneous Radio-Ablation Using BAT-90: Results of an Ongoing …

Malkhaz Mizandari

ASCO GI 2023 NRG/RTOG 1112 Randomized Phase 3 Study: Sorafenib vs. S…

ASCO GI 2023 Conference Coverage

L. Dawson

Year in Review: GI Radiation Oncology

OncoAlert

E. Miller

Local Ablative Treatment of Small Hepatocellular Carcinoma: What Are…

Houston Methodist

L. Kulik

ASCO 2022 on Atezolizumab + Bevacizumab vs Lenvatinib or Sorafenib i…

ASCO 2022 Conference Coverage

M. Rimini

The Path Ahead: Imaging-Based Hepatology

Yale School of Medicine

J. Weinreb

Viral Hepatitis in the Outpatient Setting

University of Colorado Department of Medicine

A. Kalra

Liver Cancers: Hepatocellular Carcinoma & Cholangiocarcinoma - Curre…

Houston Methodist

A. Connor, A. O. Kaseb, S. Kodali

ASCO GI 2023 CCTG HE.1 - Phase 3 Study: Palliative RT for Symptomati…

ASCO GI 2023 Conference Coverage

L. Dawson

Advances in HCC

Scripps Health

C. Frenette

Liver Directed Therapy in 2021: What Are the Advances in Transarteri…

UCLA Health

S. Padia

Hepatocellular Carcinoma Updates for the Gastroenterologist

Cedars Sinai

J. Dong Yang

Hepatology in 2022: Open Questions

Yale School of Medicine

M. Colombo

Systemic Therapies for HCC: What Does the Gastroenterologist Need to…

35th Annual New Treatments in Chronic Liver Disease

C. Frenette, J. Gutierrez, C. J. Karvellas

NW AASLD Review 2021: Cirrhotic Complications

Northwestern Medicine Gastroenterology

C. Moore

HCC in Intermediate BCLC B: How TACE Affects Median OS? Is TACE/TARE…

Cedars Sinai

J. Marrero, W. C. Maddrey

Therapeutics & Sequencing in HCC: What Are the Optimal Choices for 1…

Cedars Sinai

J. Marrero, W. C. Maddrey

Towards a Practical Approach to HCC Management: Focus on Emerging Im…

Houston Methodist

A. O. Kaseb